Medpace Holdings, Inc.
MEDP
Rang in aandelen
#1306
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a... Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
Aandeelprijs
$622.03
Laatst gesynchroniseerd: 2026-10-20
Marktkapitalisatie
$17.36B
Verandering (1 dag)
0.38%
Verandering (1 jaar)
14.00%
Land
US
Handel Medpace Holdings, Inc. (MEDP)
Categorie
Healthcare
P/B-ratio voor Medpace Holdings, Inc. (MEDP)
P/B-ratio op October 2026 TTM: 40.23
Volgens de meest recente financiële rapporten en aandelenkoers van Medpace Holdings, Inc. is de huidige P/B-ratio (TTM) 40.23. Eind 2024 had het bedrijf een P/B-ratio van 12.46.
P/B-ratiohistoriek voor Medpace Holdings, Inc. van 2013 tot 2026
P/B-ratio aan het einde van elk jaar
| Jaar | P/B-ratio | Wijzigen |
|---|---|---|
| 2026 (TTM) | 40.23 | 14.01% |
| 2025 | 35.29 | 183.28% |
| 2024 | 12.46 | -26.06% |
| 2023 | 16.85 | -5.37% |
| 2022 | 17.80 | 117.38% |
| 2021 | 8.19 | 33.05% |
| 2020 | 6.16 | 48.23% |
| 2019 | 4.15 | 30.16% |
| 2018 | 3.19 | 13.44% |
| 2017 | 2.81 | 33.43% |
| 2016 | 2.11 | -20.86% |
| 2015 | 2.66 | 30.90% |
| 2014 | 2.03 | 0.00% |
| 2013 | 0.00 | 0.00% |
P/B-ratio voor vergelijkbare bedrijven of concurrenten
| Bedrijf | P/B-ratio | Verschil in P/B-ratio | Land |
|---|---|---|---|
| 4.7411 | -88.22% |
US
|
|
| 3.0143 | -92.51% |
US
|
|
| 31.051 | -22.82% |
US
|
|
| - | - |
CN
|
|
| 6.6641 | -83.44% |
US
|
